Ymabs broken uptrend and reversed badly

NASDAQ:YMAB   Y-mAbs Therapeutics, Inc
Expecting ymabs to hit its sma 100/200 at 32.5-34 before finding support again. Unless (as is always the case with pharma ) we get some good news


The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.